[Heavy-chain antibodies of the Camelidae and their possible applications]
- PMID: 15928603
[Heavy-chain antibodies of the Camelidae and their possible applications]
Abstract
The immunoglobulins of the Camelidae family belonging to subclasses IgG2 and IgG3 consist of heavy chains only. The lack of light chains is caused by a point mutation in the heavy-chain gene, resulting in the loss of the splice consensus signal and the removal of the entire CH1 domain together with introns. The heavy-chains antibodies also contain longer hinge regions and conservative amino-acid substitutions in the framework regions. Despite the lack of light chains, the heavy-chain antibodies reveal normal antigen binding ability and effector functions. The heavy-chain antibodies are relatively easy to clone and possess good stability, high specificity, low molecular weight, and the ability to recognize unique epitopes. Possible areas of application of heavy-chain antibodies include their use as in vivo imaging reagents and sources of peptide-based drugs.
Similar articles
-
Loss of splice consensus signal is responsible for the removal of the entire C(H)1 domain of the functional camel IGG2A heavy-chain antibodies.Mol Immunol. 1999 Jun;36(8):515-24. doi: 10.1016/s0161-5890(99)00067-x. Mol Immunol. 1999. PMID: 10475606
-
Application of monoclonal antibodies in functional and comparative investigations of heavy-chain immunoglobulins in new world camelids.Clin Diagn Lab Immunol. 2005 Mar;12(3):380-6. doi: 10.1128/CDLI.12.3.380-386.2005. Clin Diagn Lab Immunol. 2005. PMID: 15753251 Free PMC article.
-
Introduction to heavy chain antibodies and derived Nanobodies.Methods Mol Biol. 2012;911:15-26. doi: 10.1007/978-1-61779-968-6_2. Methods Mol Biol. 2012. PMID: 22886243 Review.
-
Induction of immune responses and molecular cloning of the heavy chain antibody repertoire of Lama glama.J Immunol Methods. 2000 Jun 23;240(1-2):185-95. doi: 10.1016/s0022-1759(00)00188-5. J Immunol Methods. 2000. PMID: 10854612
-
Antibody repertoire development in camelids.Dev Comp Immunol. 2006;30(1-2):187-98. doi: 10.1016/j.dci.2005.06.010. Dev Comp Immunol. 2006. PMID: 16051357 Review.
Cited by
-
VHH Nanobody Versatility against Pentameric Ligand-Gated Ion Channels.J Med Chem. 2024 Jun 13;67(11):8502-8518. doi: 10.1021/acs.jmedchem.4c00231. Epub 2024 Jun 3. J Med Chem. 2024. PMID: 38829690 Free PMC article. Review.